Suppr超能文献

关注危重症患者的外周静脉穿刺中心静脉导管

Focus on peripherally inserted central catheters in critically ill patients.

作者信息

Cotogni Paolo, Pittiruti Mauro

机构信息

Paolo Cotogni, Anesthesiology and Intensive Care, Department of Medicine, S. Giovanni Battista Hospital, University of Turin, 10123 Turin, Italy.

出版信息

World J Crit Care Med. 2014 Nov 4;3(4):80-94. doi: 10.5492/wjccm.v3.i4.80.

Abstract

Venous access devices are of pivotal importance for an increasing number of critically ill patients in a variety of disease states and in a variety of clinical settings (emergency, intensive care, surgery) and for different purposes (fluids or drugs infusions, parenteral nutrition, antibiotic therapy, hemodynamic monitoring, procedures of dialysis/apheresis). However, healthcare professionals are commonly worried about the possible consequences that may result using a central venous access device (CVAD) (mainly, bloodstream infections and thrombosis), both peripherally inserted central catheters (PICCs) and centrally inserted central catheters (CICCs). This review aims to discuss indications, insertion techniques, and care of PICCs in critically ill patients. PICCs have many advantages over standard CICCs. First of all, their insertion is easy and safe -due to their placement into peripheral veins of the arm- and the advantage of a central location of catheter tip suitable for all osmolarity and pH solutions. Using the ultrasound-guidance for the PICC insertion, the risk of hemothorax and pneumothorax can be avoided, as well as the possibility of primary malposition is very low. PICC placement is also appropriate to avoid post-procedural hemorrhage in patients with an abnormal coagulative state who need a CVAD. Some limits previously ascribed to PICCs (i.e., low flow rates, difficult central venous pressure monitoring, lack of safety for radio-diagnostic procedures, single-lumen) have delayed their start up in the intensive care units as common practice. Though, the recent development of power-injectable PICCs overcomes these technical limitations and PICCs have started to spread in critical care settings. Two important take-home messages may be drawn from this review. First, the incidence of complications varies depending on venous accesses and healthcare professionals should be aware of the different clinical performance as well as of the different risks associated with each type of CVAD (CICCs or PICCs). Second, an inappropriate CVAD choice and, particularly, an inadequate insertion technique are relevant-and often not recognized-potential risk factors for complications in critically ill patients. We strongly believe that all healthcare professionals involved in the choice, insertion or management of CVADs in critically ill patients should know all potential risk factors of complications. This knowledge may minimize complications and guarantee longevity to the CVAD optimizing the risk/benefit ratio of CVAD insertion and use. Proper management of CVADs in critical care saves lines and lives. Much evidence from the medical literature and from the clinical practice supports our belief that, compared to CICCs, the so-called power-injectable peripherally inserted central catheters are a good alternative choice in critical care.

摘要

对于越来越多处于各种疾病状态、在各种临床环境(急诊、重症监护、手术)且出于不同目的(输液或药物输注、肠外营养、抗生素治疗、血流动力学监测、透析/血液滤过程序)的重症患者而言,静脉通路装置至关重要。然而,医护人员通常担心使用中心静脉通路装置(CVAD)(主要是外周静脉穿刺中心静脉导管(PICC)和中心静脉穿刺中心静脉导管(CICC))可能导致的后果(主要是血流感染和血栓形成)。本综述旨在讨论重症患者中PICC的适应证、置入技术及护理。与标准CICC相比,PICC有许多优点。首先,其置入简便且安全——因其置于手臂的外周静脉——且导管尖端位于中心位置,适用于所有渗透压和pH值的溶液。使用超声引导进行PICC置入,可避免血胸和气胸的风险,且初始位置不当的可能性也很低。对于凝血状态异常且需要CVAD的患者,PICC置入也适合避免术后出血。以前归因于PICC的一些局限性(即流速低、中心静脉压监测困难、放射诊断程序缺乏安全性、单腔)延迟了其在重症监护病房作为常规操作的应用。不过,可动力注射PICC的最新发展克服了这些技术局限性,PICC已开始在重症监护环境中推广。从本综述中可以得出两个重要的关键信息。第一,并发症的发生率因静脉通路而异,医护人员应了解每种类型CVAD(CICC或PICC)的不同临床表现以及相关的不同风险。第二,CVAD选择不当,尤其是置入技术不当,是重症患者并发症的相关且往往未被认识到的潜在风险因素。我们坚信,所有参与重症患者CVAD选择、置入或管理的医护人员都应了解并发症的所有潜在风险因素。这些知识可将并发症降至最低,并通过优化CVAD置入和使用的风险/效益比来保证CVAD的使用寿命。重症监护中CVAD的正确管理可挽救导管和生命。医学文献和临床实践的大量证据支持我们的观点,即与CICC相比,所谓的可动力注射外周静脉穿刺中心静脉导管在重症监护中是一个不错的替代选择。

相似文献

1
Focus on peripherally inserted central catheters in critically ill patients.
World J Crit Care Med. 2014 Nov 4;3(4):80-94. doi: 10.5492/wjccm.v3.i4.80.
2
The safety of peripherally inserted central venous catheters in critically ill patients: A retrospective observational study.
J Vasc Access. 2024 Sep;25(5):1479-1485. doi: 10.1177/11297298231169059. Epub 2023 Apr 18.
7
Peripherally inserted central catheters for parenteral nutrition: a comparison with centrally inserted catheters.
JPEN J Parenter Enteral Nutr. 1999 Mar-Apr;23(2):85-9. doi: 10.1177/014860719902300285.
8
Comparative thrombosis risk of vascular access devices among critically ill medical patients.
Thromb Res. 2018 Dec;172:54-60. doi: 10.1016/j.thromres.2018.10.013. Epub 2018 Oct 19.
9
Catheter-related complications in onco-hematologic children: A retrospective clinical study on 227 central venous access devices.
J Vasc Access. 2024 Mar;25(2):512-518. doi: 10.1177/11297298221122128. Epub 2022 Sep 14.
10

引用本文的文献

3
Jugular Venous Catheterization is Not Associated with Increased Complications in Patients with Aneurysmal Subarachnoid Hemorrhage.
Neurocrit Care. 2025 Jun;42(3):929-936. doi: 10.1007/s12028-024-02173-1. Epub 2024 Nov 26.
4
Performance and safety of PowerPICC catheters and accessories: a prospective observational study.
BMJ Open. 2024 Sep 30;14(9):e081288. doi: 10.1136/bmjopen-2023-081288.
5
A modified method for measuring the length of peripherally inserted central catheters to reduce the risk of malposition during catheter insertion.
SAGE Open Med. 2023 Oct 10;11:20503121231204488. doi: 10.1177/20503121231204488. eCollection 2023.
7
Validation of the PICC length prediction formula based on anteroposterior chest radiographs for bedside ultrasound-guided placement.
PLoS One. 2022 Nov 11;17(11):e0277526. doi: 10.1371/journal.pone.0277526. eCollection 2022.
10
Study on the effect of PICC in parenteral nutrition support for colorectal cancer.
Am J Transl Res. 2021 Aug 15;13(8):9839-9845. eCollection 2021.

本文引用的文献

2
The safety and efficacy of bedside removal of tunneled hemodialysis catheters by nephrology trainees.
Ren Fail. 2013 Oct;35(9):1264-8. doi: 10.3109/0886022X.2013.823875. Epub 2013 Aug 7.
3
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.
Lancet. 2013 Jul 27;382(9889):311-25. doi: 10.1016/S0140-6736(13)60592-9. Epub 2013 May 20.
4
Hemodialysis vascular access: everything you always wanted to know about it (but were afraid to ask).
J Nephrol. 2013 Sep-Oct;26(5):836-47. doi: 10.5301/jn.5000209. Epub 2012 Sep 19.
5
Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days.
JPEN J Parenter Enteral Nutr. 2013 May-Jun;37(3):375-83. doi: 10.1177/0148607112460552. Epub 2012 Sep 20.
7
International evidence-based recommendations on ultrasound-guided vascular access.
Intensive Care Med. 2012 Jul;38(7):1105-17. doi: 10.1007/s00134-012-2597-x. Epub 2012 May 22.
8
Ultrasound guided central vascular access in neonates, infants and children.
Curr Drug Targets. 2012 Jun;13(7):961-9. doi: 10.2174/138945012800675696.
9
Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
Crit Care Med. 2012 Jun;40(6):1820-6. doi: 10.1097/CCM.0b013e31824e11b4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验